ProtoKinetix' AAGP(TM) World Wide Patents Have Been Filed

08-Dec-2005

ProtoKinetix, Inc.'s president and CEO, Dr. John Todd, announced that Cabinet Moutard, patent specialists in France, have completed filing the AAGP(TM) patents. This extremely detailed filing is a world wide patent of the anti-aging glycoprotein family of molecules. The patents include all practical derivatives, variations and extensions of the AAGP(TM) molecule plus all applications.

Other news from the department research and development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances